These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lisuride in de novo parkinsonian patients: a four-year follow-up. Giovannini P; Scigliano G; Piccolo I; Soliveri P; Suchy I; Caraceni T Acta Neurol Scand; 1988 Apr; 77(4):322-7. PubMed ID: 3291546 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of lisuride in advanced Parkinson's disease. Meneghetti G; Bracco F; Giometto B; Ferla S; Schergna E Eur Neurol; 1986; 25(1):74-80. PubMed ID: 3510126 [TBL] [Abstract][Full Text] [Related]
4. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease. Rinne UK Neurology; 1989 Mar; 39(3):336-9. PubMed ID: 2927639 [TBL] [Abstract][Full Text] [Related]
6. Combination of a dopamine agonist, MAO-B inhibitor and levodopa--a new strategy in the treatment of early Parkinson's disease. Rinne UK Acta Neurol Scand Suppl; 1989; 126():165-9. PubMed ID: 2515722 [TBL] [Abstract][Full Text] [Related]
7. [Lisuride in the combination treatment of Parkinson disease]. Jellinger K Wien Med Wochenschr; 1987 Apr; 137(7-8):155-9. PubMed ID: 3111099 [TBL] [Abstract][Full Text] [Related]
8. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa. Lieberman A; Goldstein M; Neophytides A; Kupersmith M; Leibowitz M; Zasorin N; Walker R; Kleinberg D Neurology; 1981 Aug; 31(8):961-5. PubMed ID: 7022259 [TBL] [Abstract][Full Text] [Related]
9. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052 [No Abstract] [Full Text] [Related]
10. [Oral lisuride in Parkinson's disease]. Obeso JA; Luquin MR; MartÃnez Lage JM Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822 [No Abstract] [Full Text] [Related]
11. The use of lisuride in severe Parkinson's disease. Chin D; Yu YL; Huang CY Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512 [TBL] [Abstract][Full Text] [Related]
12. Lisuride in the treatment of Parkinsonism. Schachter M; Sheehy MP; Parkes JD; Marsden CD Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157 [TBL] [Abstract][Full Text] [Related]
13. Further studies with lisuride in Parkinson's disease. Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E Eur Neurol; 1983; 22(2):119-23. PubMed ID: 6341071 [TBL] [Abstract][Full Text] [Related]
14. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease. Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057 [No Abstract] [Full Text] [Related]
15. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease. Obeso JA; Luquin MR; MartÃnez Lage JM Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037 [TBL] [Abstract][Full Text] [Related]